Le Lézard
Classified in: Health, Business
Subjects: FNC, CXP

Plastic Surgery and Aesthetics Dominate Private Equity's Attention in 2022 with Viper Equity Partners providing major deal flow.


PALM BEACH, Fla., Jan. 20, 2022 /PRNewswire/ -- In 2017 Viper Equity Partners saw plastic surgery as the next big private equity target. They began signing up marquee offices nation wide and courting buyers to pay attention. Since then, they have closed 200m in transactions which they consider to be only the beginning of a 10-year run. "The first couple years were tough trying to gain interest from our PE partners," stated David C. Branch, Viper's founder. "We knew it would be huge once it started but, in those days, it was deal by deal," stated Branch.

Fast forward to 2022, the market is extremely busy. Private equity firms are flooding the market with new platforms focused on med spas, aesthetics, and plastic surgery offices of all specialties. The industry just makes sense. From the revenue side there is insurance, fee for service and an enormous flow of recurring revenue streams. Procedures range from premium cost surgeries to moderately priced noninvasive options available using nurses and physician assistants. The reality of people living longer and the desire to look better coupled with a surging economy makes it a must have business model.

Viper presently has a large inventory of practices and roll ups available for acquisition. "We have targeted individual deals with EBITDAS in the 3-5m dollar range and roll ups with over 10m," stated Samir Qureshi, Viper's President of their Aesthetics division. "Our goal is to be able to meet the needs of all buyers depending on their growth strategy," stated Samir.

There also has been some extraordinarily successful mergers with dermatology and plastic surgery groups. This move brings cross-referral revenues in house along with the strong insurance revenues that Dermatology offices have. Two business models that align perfectly together.

Viper is presently looking for plastic surgery offices, both cosmetic and reconstructive, nationwide with multi locations and revenues above 10m. They also have room in two med spa rollups in the mid-west and southeast. Contact Viper for more information.

Viper Equity Partners is a sell side investment banking firm located in Palm Beach Florida. They are industry leaders in Dental, Dermatology, Plastic Surgery, Ophthalmology and Real estate transactions. For more information and a free industry brochure visit www.Viperequitypartners.com or contact Samir Qureshi at 305 281 5259 [email protected].

SOURCE Viper Equity Partners


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: